Colonoscopy Devices Market is expected to reach US$ 4,112.97 million by 2034

Colonoscopes Segment Leading the Colonoscopy Devices Market by Product Type

According to our new research study on “Colonoscopy Devices Market Forecast to 2034 – Global Analysis – by product type, end user,” the Colonoscopy Devices Market size is expected to grow from US$ 2,411.46 million in 2025 to US$ 4,112.97 million by 2034, with a CAGR of 6.1% during 2025–2034. Development in the Colonoscopy Devices Market is taking place through increasing use of minimally invasive methods in treating abdominal and thoracic aortic disease cases. These innovations in colonoscope design, high-definition visualization, image enhancement, navigation, and computer-assisted detection are playing an important role in improving the quality of colon examinations and identifying the lesions. The market is slowly moving from conventional colonoscopy equipment to advanced high-definition, image-enhanced, AI-assisted and disposable colonoscopy products for overcoming challenging anatomy, subtle lesions, and reprocessing. Besides, the advancements in NBI, chromoendoscopy, AI detection in real time and cloud-based endoscopy systems are assisting in performing detailed mucosal assessment and standardized lesion detection. Adenoma detection, complete examination, efficiency, and infection prevention are some of the aspects that are driving innovations in the market products. Single-use, robotic, and autonomous colonoscopy platforms are other trends in the market.

The increase in colorectal cancer (CRC) cases in younger people has become a significant public health issue because the trend is no longer following the declining pattern that has been observed for many years in older adults. While the CRC risk increases with aging, there have been enough incidences in younger people to affect policy decisions and healthcare practice. The American Cancer Society (ACS, 2024) reported that CRC had become the number one cancer death cause among males younger than 50 and the second one among females within the same age range. There is still not much understanding of the reasons behind the phenomenon, but the changes in lifestyles and exposure to the environment in consecutive generations have been suggested as possible ones.

The mentioned shift has implications for the Colonoscopy Devices Market because early disease appearance increases the need for visualization, lesion detection, biopsy, and polypectomy. As per the stats presented in March 2026 by the American Cancer Society (ACS), in 2026 approximately 108,860 cases of CRC are expected to be diagnosed in the US, with about 55,230 deaths.

Therefore, the rise in the incidence of CRC in young adults will lead to continued demand for colonoscopy procedures and colonoscopy instruments as health care providers aim to increase early diagnosis and treatment through prevention. For manufacturers, the increasing number of people to screen will provide avenues for the design of colonoscopes that will have high visualization, maneuverability, high-quality images, and lesion detection capabilities. For health care providers, the increasing number of screenings may spur them to invest in endoscopic infrastructure and efficiency. Nevertheless, the fact that the rate of screening for CRC among young adults remains low means that any expansion in the market will require more than just increased disease burden.

The creation of robotic colonoscopy platforms constitutes a continuing technological evolution from manually controlled to robotic devices that are able to help or to perform autonomously certain phases of the procedure. In the case of conventional colonoscope insertion, technical skills are required due to the fact that the endoscope has to be continuously maneuvered along a flexible and anatomically varying organ with control of insertion, withdrawal, rotation, and distal tip angulation. Such a need has motivated research into robotic platforms that could mimic the skills of the experienced endoscopist, interact in a controlled way with the colonic walls, and increase the degree of automation of the process.

Researchers from the University of Occupational and Environmental Health and Kyushu Institute of Technology demonstrated development of the Autonomous Colonoscope Robot System (ACRS) in 2025 through utilization of colonoscope insertion data gathered from experts to program the automated navigation system. A total of 62 of the 72 evaluable automated insertions met the criteria of Level 4 classification of fully autonomous during a colonoscopy training model proving the feasibility without crossing into the realm of clinical application. Meanwhile, the CARE I study of Neptune Medical's Triton 4.0 robotic endoscope was conducted starting from 2025 on ClinicalTrials.gov.

Product development is shifting away from modifications of traditional flexible scopes towards developing scopes with robotic propulsion capabilities, automated steering capability, force monitoring, and more advanced navigation interface. At the same time, the need for clinical validation, evaluation of safety and performance in complex anatomical structure of humans is slowing down the pace at which autonomous technologies shift from experimental to clinical product. The development of autonomous functionalities is becoming a more and more common feature of the technological evolution in the market as research advances.

EndoMed Systems GmbH, FUJIFILM Holdings Corporation, PENTAX Medical, Ottomed, Olympus Corporation, Medtronic plc, SonoScape Medical Corp., Boston Scientific Corporation, Guangzhou Red Pine Medical Instrument Co., Ltd. and EndoFresh. are among the leading companies profiled in the Colonoscopy Devices Market report.

By product, the market is segmented into colonoscopes, visualization systems and others. By disease indication the market has segmented into colorectal cancer, lynch syndrome, ulcerative colitis, Crohn's disease, others based on end user, the market is segmented into hospitals, ambulatory surgery center and other end users. By geography, the market is divided into North America (the US, Canada and Mexico), Europe (Germany, United Kingdom, France, Italy, Spain and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, Rest of MEA) and South & Central America (Brazil, Argentina and Rest of SCAM).